Energy loss and adults with congenital heart disease: a novel marker of cardiac workload beyond right ventricular size

能量损失与先天性心脏病成人:除右心室大小外,心脏负荷的新型标志物

阅读:2

Abstract

Right ventricular (RV) dysfunction after biventricular repair is critical in most adults with congenital heart disease (ACHD). Conventional 2D magnetic resonance imaging (MRI) measurement is considered as a 'gold standard' for RV evaluation; however, addition information on ACHD after biventricular repair is sometimes required. The reasons why adjunctive information is required is as follows: (I) to evaluate the severity of cardiac burden in symptomatic patients with normal RV size and ejection fraction (EF), (II) to determine the optimal timing of invasive treatments in asymptomatic ones, and (III) to detect proactively a potential cardiac burden leading to ventricular deterioration, from a fluid dynamics perspective. Energy loss (EL) using 4D flow MRI is a novel non-invasive flow visualisation method, and EL using 4D flow MRI can be a potential marker of cardiac burden. EL is the energy dissipated by blood viscosity, and evaluates the cardiac workload related to the prognosis of heart failure. The advantages are as follows: EL can detect cardiac overload which integrates both afterload and preload. EL is an independent parameter of current heart failure or cardiac remodeling state, such as chamber size or ventricular wall motion. This parameter is based on intuitive and clear physiological concepts, suitable for in vivo flow measurements using inner velocity profiles without a pressure-volume loop. The possible clinical applications of EL are as follows: (I) to follow the temporal changes in each patient and (II) to calculate the percentage of cardiac burden by combining pressure data from catheterisation. Although EL appears to be an ideal marker of haemodynamics from a fluid dynamics perspective, EL measurement using 4D flow MRI has some limitations. Flow dynamics software is still being developed, both technically and methodologically, and its clinical impact on long-term outcomes remains unknown. Therefore, further studies are warranted.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。